Angiogenesis is an essential factor for cancer progression. Although more attention is paid in angiogenesis on its role in cancer biology, many other non-neoplastic diseases are also angiogenic-dependent. Recently, there is motivation to control cancer via inhibition of angiogenesis. Isatin-based scaffolds have been extensively used as anticancer agents in the recent years. Although some biological properties of isatin-based scaffolds are determined, their effects on angiogenesis are rare. So, we investigated the antiangiogenic effects of isatin-1,2,4-triazole conjugates. (Z)-3-((5-(benzylthio)-4H-1,2,4-triazol-3-yl)imino)-5-haloindolin-2-one macromolecules 1a–1l were synthesized and characterized, and the buffered solutions were used for evaluation of their cytotoxicity (cell viability) by MTT assay in vitro against U87MG (human glioblastoma astrocytoma) and A2780 (human ovarian carcinoma) cancer cell lines. Also, the effects of the compounds 1a–1l on supernatants activities and levels of matrix metalloproteinases (MMP-2 and MMP-9) were assayed using enzyme-linked immunosorbent assay (ELISA) and gelatin zymography. The compounds 1j–1l have the greatest cytotoxicity against studied cell lines. Moreover, our observations indicated that 1j–1l decreased the supernatants activity of MMP-2 and MMP-9 more than the others and all of the tested compounds considerably decreased the supernatant levels of MMP-9. The molecular mechanism of 1j binding to MMP-2 and MMP-9 was investigated by fluorescence quenching, absorption spectroscopy, FT-IR, molecular docking and molecular dynamics (MD) simulation procedures.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100, 57–70 (2000)
A. Aliabadi, Z. Hasanvand, A. Kiani, S. Mirabdalib, Synthesis and in vitro cytotoxicity assessment of N-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with potential anticancer activity. Iran. J. Pharm. Res. 12, 687–693 (2013)
C. Ruhrberg, Endogenous inhibitors of angiogenesis. J. Cell Sci. 114(18), 3215–3216 (2001)
A. Aliabadi, E. Eghbalian, Kiani A Synthesis and evaluation of the cytotoxicity of a series of 1,3,4-thiadiazole based compounds as anticancer agents. Iran. J. Basic Med. Sci. 16, 1133–1138 (2013)
S. Lakhan, M. Avramut, matrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets. Pain Res. Treat. 2012, 10 (2012)
A.R. Nelson, B. Fingleton, M.L. Rothenberg, L.M. Matrisian, Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18, 1135–1149 (2000)
P.F. Mercer, J.K. Shute, A. Bhowmik, G.C. Donaldson, J.A. Wedzicha, J.A. Warner, MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir. Res. 6, 150–159 (2005)
M. Bérubé, A. Deschambeault, M. Boucher, L. Germain, E. Petitclerc, S.L. Guérin, MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment. Mol. Vis. 11, 1101–1111 (2005)
T. Sato, T. Sakai, Y. Noguchi, M. Takta, S. Hirakawa, A. Ito, Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol. Oncol. 92, 47–56 (2004)
L.A. Di Nezza, A. Misajon, J. Zhang, T. Jobling, M.A. Quinn, A.G. Ostör, G. Nie, A. Lopata, L.A. Salamonsen, Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 2002(94), 1466–1475 (2002)
D.W. Cottam, I.G. Rennie, K. Woods, M.A. Parsons, R.A. Bunning, R.C. Rees, Gelatinolytic metalloproteinase secretion patterns in ocular melanoma. Investig. Ophthalmol. Vis. Sci. 32, 1923–1927 (1992)
D.A. Fishman, L. Bafetti, S. Banionis, A.S. Kearns, K. Chilukuri, M.S. Stack, Production of extracellular matrix degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells. Cancer 80, 1457–1463 (1997)
G. Garzetti, A. Ciavattini, G. Lucarini, G. Goteri, M. De Nicolis, S. Garbisa, L. Masiero, C. Romanini, B. Graziella, Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystadenocarcinomas: clinical and prognostic implications. Anticancer Res. 15, 2799–2804 (1995)
K. Gohji, N. Fujomoto, I. Hara, A. Fujii, A. Gotoh, H. Okada, S. Arakawa, S. Kitazawa, H. Miyake, S. Kamidono, M. Nakijima, Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int. J. Cancer 79, 96–101 (1998)
L. Hou, C. Ju, J. Zhang, J. Song, Y. Ge, W. Yue, Antitumor effects of Isatin on human neuroblastoma cell line (SH-SY5Y) and the related mechanism. Eur. J. Pharm. 589, 27–31 (2008)
G. Cerchiaro, A.M.C. Ferreira, Oxindoles and copper complexes with oxindole-derivatives as potential pharmacological agents. J. Braz. Chem. Soc. 17, 1473–1485 (2006)
M.C. Rodríguez-Argüelles, R. Cao, A.M. García-Deibe, C. Pelizzi, J. Sanmartín-Matalobos, F. Zani, Antibacterial and antifungal activity of metal(II) complexes of acylhydrazones of 3-isatin and 3-(N-methyl)isatin. Polyhedron 28, 2187–2195 (2009)
A. Patel, S. Bari, G. Talele, J. Patel, M. Sarangapani, Synthesis and antimicrobial activity of some new isatin derivatives. Iran. J. Pharm. Res. 4, 249–254 (2006)
P. Pakravan, S. Kashanian, M.M. Khodaei, F.G. Harding, Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity. Pharmacol. Rep. 65, 313–335 (2013)
S.N. Pandeya, S. Smitha, M. Jyoti, S.K. Sridhar, Biological activities of isatin and its derivatives. Acta Pharm. 55, 27–46 (2005)
S.N. Pandeya, J.R. Dimmock, Recent evaluations of thiosemicarbazones and semicarbazones and related compounds for antineoplastic and anticonvulsant activities. Pharmazie 48, 659–666 (1993)
I. Chiyanzu, E. Hansell, J. Gut, P.J. Rosenthal, J.H. McKerrow, K. Chibale, Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg. Med. Chem. Lett. 13, 3527–3530 (2003)
V.E. Ivanov, N.G. Tikhomirova, A.B. Tomchin, N.V. Razukrantova, Antimicrobial and antibacterial activity of isatin thiosemicarbazones and their complex copper complexes (II) and (I). Pharm. Chem. J. 23, 413–415 (1989)
Y. Teitz, D. Ronen, A. Vansover, T. Stematsky, J.L. Riggs, Inhibition of human immunodeficiency virus by N-methylisatin-b-40:40 diethylthiosemicarbazone and N-allyl isatin-b -40:40 diallylthiosemicarbazone. Antiviral Res. 24, 305–314 (1994)
H. Adibi, M.M. Khodaei, P. Pakravan, R. Abiri, Synthesis, characterization, and in vitro antimicrobial evaluation of hydrazone and bishydrazone derivatives of isatin. Pharm. Chem. J. 44(4), 219–227 (2010)
S. Kashanian, M.M. Khodaei, P. Pakravan, H. Adibi, Molecular aspects on the interaction of isatin-3-isonicotinylhydrazone to deoxyribonucleic acid: model for intercalative drug-DNA binding. Mol. Biol. Rep. 39(4), 3853–3861 (2012)
A. Mavrova, D. Wesselinova, Examinations on the cytotoxicity of some 2,5-disubstitute-1,2,4-triazoles and 1,3,4-thiadiazole and their precursors towards guinea hen cells. J. Univ. Chem. Technol. Met. 47, 251–256 (2012)
V. Padmavathi, G.S. Reddy, A. Padmaja, P. Kondaiah, A. Shazia, Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles. Eur. J. Med. Chem. 44, 2106–2112 (2009)
M.S.R. Murty, K.R. Ram, R.V. Rao, J.S. Yadav, J.V. Rao, R. Pamanji, L.R. Velatooru, Synthesis of new S-alkylated-3-mercapto-1,2,4-triazole derivatives bearing cyclic amine moiety as potent anticancer agents. Lett. Drug Des. Discov. 9, 276–281 (2012)
A. Adibi, N. Zandieh, M. Mansouri, Cytotoxic effects of palladium complexes containing squaric ligands and sulfosuccinic acid on cancer cell lines. J. Kermanshah Univ. Med. Sci. 18(11), 619–630 (2015)
H. Adibi, L. Hosseinzadeh, S. Farhadi, F. Ahmadi, Synthesis and cytotoxic evaluation of 6-amino-4-aryl-3-methyl-2, 4-dihydropyrano[2,3-C]pyrazole-carbonitrile derivatives using borax with potential anticancer effects. J. Rep. Pharm. Sci. 2(2), 27–35 (2013)
H. Adibi, L. Hosseizadeh, M. Mahdian, A. Foroumadi, M.A. Zolfigol, Synthesis of 7-substituted fluoroquinolone derivatives containing triazolidine dione moiety and in vitro evaluation of their cytotoxic effects. J. Rep. Pharm. Sci. 2(1), 59–66 (2013)
H. Adibi, R. Khodarahmi, K. Mansouri, M. Khaleghi, S. Maghsoudi, Synthesis of 4-aryl-4H-chromene derivatives with boric acid: evaluation of their in vitro anti-angiogenesis effects and possible mechanism of action. Pharm. Sci. 19(1), 23–30 (2013)
H. Adibi, M.B. Majnooni, A. Mostafaie, K. Mansouri, M. Mohammadi, Synthesis, and In-vitro cytotoxicity studies of a series of triazene derivatives on human cancer cell lines. Iran. J. Pharm. Res. 12(4), 695–703 (2013)
N. Abdollahpour, A. Asoodeh, M.R. Saberi, J. Chamani, Separate and simultaneous binding effects of aspirin and amlodipine to human serum albumin based on fluorescence spectroscopic and molecular modeling characterizations: a mechanistic insight for determining usage drugs doses. J Lumin. 131(9), 1885–1899 (2011)
S. Ashoka, J. Seetharamappa, P.B. Kandagal, Shaikh SMT Investigation of the interaction between trazodone hydrochloride and bovine serum albumin. J. Lumin. 121(1), 179–186 (2006)
M.R. Ashrafi-Kooshk, N. Moradi, S. Ghobadi, M. Shahlaei, R. Khodarahmi, Spectroscopic study of drug-binding characteristics of unmodified and pNPA-based acetylated human serum albumin: does esterase activity affect microenvironment of drug binding sites on the protein? J. Lumin. 160, 351–361 (2015)
M. Shahlaei, B. Rahimi, M.R. Ashrafi-Kooshk, K. Sadrjavadi, R. Khodarahmi, Probing of possible olanzapine binding site on human serum albumin: combination of spectroscopic methods and molecular dynamics simulation. J. Lumin. 158, 91–98 (2015)
W.K. Surewicz, H.H. Mantsch, D. Chapman, Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment. Biochem 32(2), 389–394 (1993)
A. Naseri, S. Hosseini, F. Rasoulzadeh, M.-R. Rashidi, M. Zakery, Khayamian T (2015) Interaction of norfloxacin with bovine serum albumin studied by different spectrometric methods; displacement studies, molecular modeling and chemometrics approaches. J. Lumin. 157, 104–112 (2015)
D.M. Byler, H. Susi, Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers 25(3), 469–487 (1986)
A. Dong, P. Huang, W.S. Caughey, Protein secondary structures in water from second-derivative amide I infrared spectra. Biochem 29(13), 3303–3308 (1990)
H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T. Bhat, H. Weissig, I.N. Shindyalov, P.E. Bourne, The protein data bank. Nucl. Acids Res. 28(1), 235–242 (2000)
G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, A.J. Olson, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19(14), 1639–1662 (1998)
H.J. Berendsen, D. van der Spoel, R. van Drunen, GROMACS: a message-passing parallel molecular dynamics implementation. Comput. Phys. Commun. 91(1), 43–56 (1995)
B. Hess, C. Kutzner, D. Van Der Spoel, E. Lindahl, GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 4(3), 435–447 (2008)
S. Melchionna, M. Barteri, G. Ciccotti, Molecular dynamics of microperoxidases in aqueous and nonaqueous solutions. J. Phys. Chem. 100(50), 19241–19250 (1996)
N. Díaz-Vergara, Á. Piñeiro, Molecular dynamics study of triosephosphate isomerase from Trypanosoma cruzi in water/decane mixture. J. Phys. Chem. B 112(11), 3529–3539 (2008)
N. Todorova, F.S. Legge, H. Treutlein, I. Yarovsky, Systematic comparison of empirical forcefields for molecular dynamic simulation of insulin. J. Phys. Chem. B 112(35), 11137–11146 (2008)
D. Van Der Spoel, E. Lindahl, Brute-force molecular dynamics simulations of villin headpiece: comparison with NMR parameters. J. Phys. Chem. B 107(40), 11178–11187 (2003)
A.W. Schüttelkopf, D.M.F. Van Aalten, PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystal Sect. D: Biol. Crystal 60(8), 1355–1363 (2004)
H.J. Berendsen, J.P.M. Postma, W.F. van Gunsteren, A. DiNola, J. Haak, Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81(8), 3684–3690 (1984)
B. Hess, H. Bekker, H.J.C. Berendsen, J.G.E.M. Fraaije, LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18(12), 1463–1472 (1997)
We gratefully acknowledge Vice Chancellery for Research and Technology, Kermanshah University of Medical Sciences, for financial support (Grant No. 94071). This article resulted from the Pharm. D thesis of Mahdi Rahpeyma, Major of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Conflict of interest
The authors declare that they have no conflict of interest.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Kiani, A., Shahlaei, M., Rahpeyma, M. et al. Synthesis of (Z)-3-((5-(benzylthio)-4H-1,2,4-triazol-3-yl)imino)-5-haloindolin-2-one derivatives: combined spectroscopic and computational investigations on the level and activity of matrix metalloproteinases 2 and 9 in cancer cell lines. J IRAN CHEM SOC (2021). https://doi.org/10.1007/s13738-020-02150-3
- Matrix metalloproteinases